Linwei Guo

816 total citations · 1 hit paper
10 papers, 468 citations indexed

About

Linwei Guo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Linwei Guo has authored 10 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Linwei Guo's work include RNA modifications and cancer (2 papers), Breast Cancer Treatment Studies (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Linwei Guo is often cited by papers focused on RNA modifications and cancer (2 papers), Breast Cancer Treatment Studies (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Linwei Guo collaborates with scholars based in China, Germany and France. Linwei Guo's co-authors include Yue Gong, Yu‐Chen Pei, Peng Ji, Ming‐Liang Jin, Yi‐Zhou Jiang, Wen-Jun Chai, Da‐Qiang Li, Yi Xiao, Tian‐Jian Yu and Ding Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cell Metabolism.

In The Last Decade

Linwei Guo

9 papers receiving 462 citations

Hit Papers

Metabolic-Pathway-Based Subtyping of Triple-Negative Brea... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linwei Guo China 7 276 221 175 117 78 10 468
Yu‐Chen Pei China 9 300 1.1× 228 1.0× 158 0.9× 100 0.9× 69 0.9× 14 502
Wen-Jun Chai China 8 278 1.0× 212 1.0× 200 1.1× 113 1.0× 115 1.5× 15 509
Silei Sui China 11 248 0.9× 131 0.6× 192 1.1× 134 1.1× 110 1.4× 13 474
Qing-Yun Chong Singapore 14 280 1.0× 184 0.8× 140 0.8× 109 0.9× 45 0.6× 16 472
Maria Apicella Italy 6 274 1.0× 191 0.9× 158 0.9× 83 0.7× 51 0.7× 6 446
Javier I. J. Orozco United States 13 309 1.1× 221 1.0× 202 1.2× 105 0.9× 58 0.7× 41 557
Tomás G. Lyons United States 10 219 0.8× 96 0.4× 219 1.3× 106 0.9× 60 0.8× 18 442
Chengyong Du China 10 329 1.2× 285 1.3× 169 1.0× 62 0.5× 108 1.4× 12 548
Ilenia Segatto Italy 14 290 1.1× 198 0.9× 251 1.4× 99 0.8× 39 0.5× 23 536
Lais Osmani United States 5 305 1.1× 192 0.9× 238 1.4× 261 2.2× 69 0.9× 10 613

Countries citing papers authored by Linwei Guo

Since Specialization
Citations

This map shows the geographic impact of Linwei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linwei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linwei Guo more than expected).

Fields of papers citing papers by Linwei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linwei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linwei Guo. The network helps show where Linwei Guo may publish in the future.

Co-authorship network of co-authors of Linwei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Linwei Guo. A scholar is included among the top collaborators of Linwei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linwei Guo. Linwei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Guo, Linwei, et al.. (2025). The Role of Plant Evolutionary History in Shaping the Variation in Specific Leaf Area Across China. Ecology and Evolution. 15(4). e71304–e71304.
2.
Luo, Hong, Linwei Guo, Xing Zheng, et al.. (2024). Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer. Cell Discovery. 10(1). 96–96. 4 indexed citations
3.
Li, Haiyun, Linwei Guo, Chenchen Wang, Xin Hu, & Ye Xu. (2023). Improving the value of molecular testing: current status and opportunities in colorectal cancer precision medicine. Cancer Biology and Medicine. 21(1). 1–8. 5 indexed citations
4.
Guo, Linwei, Chenchen Wang, Tianan Guo, et al.. (2023). Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis. Gastroenterology. 165(2). 414–428.e7. 44 indexed citations
5.
Ji, Peng, Yue Gong, Ming‐Liang Jin, et al.. (2022). In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer. Science Advances. 8(26). eabl8247–eabl8247. 56 indexed citations
6.
Guo, Linwei, Xiaoguang Li, Xun‐Xi Lu, et al.. (2021). Large‐scale genomic sequencing reveals adaptive opportunity of targeting mutated‐PI3Kα in early and advanced HER2‐positive breast cancer. SHILAP Revista de lepidopterología. 11(11). e589–e589. 10 indexed citations
7.
Gong, Yue, Peng Ji, Yun‐Song Yang, et al.. (2020). Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets. Cell Metabolism. 33(1). 51–64.e9. 296 indexed citations breakdown →
8.
Lu, Xun‐Xi, Xiaoguang Li, Hong Ling, et al.. (2020). Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer. Medical Science Monitor. 26. e925210–e925210. 6 indexed citations
9.
Zhang, Honghua, Linwei Guo, Zheng Zhang, et al.. (2019). Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival. Journal of Cancer. 10(16). 3706–3716. 31 indexed citations
10.
Guo, Linwei, Linmiao Jiang, Yue Gong, et al.. (2018). Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer. Cancer Management and Research. Volume 10. 5881–5894. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026